Skip to content

mHealth Intervention for Older Adults

Promoting Lifestyle Changes With Mobile Health Technologies for Overweight or Obese Adults With Type 2 Diabetes - Feasibility and Acceptability Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03398590
Enrollment
9
Registered
2018-01-12
Start date
2017-04-12
Completion date
2018-05-30
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Type2 Diabetes

Keywords

Type 2 Diabetes, Obesity

Brief summary

This is a pilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM.

Detailed description

This is a pilot study to test the feasibility and acceptability of a self-regulation theory-based mHealth behavior intervention for overweight or obese older adults with T2DM. The main purpose of the intervention is to increase participants' awareness of their behavior patterns and to self-regulate their daily lifestyle behaviors using the results of self-monitoring of weight and blood glucose. This is a One Group Pretest-Posttest Designed study. Ten participants will be recruited from Joslin Diabetes Center, Boston, MA. They will receive a 2-month, self-regulation theory-based weight loss intervention (five 60-minute, biweekly group sessions) and will be provided with a technology toolkit for self-monitoring including an (1) iPhone Plus, (2) the Lose It! app for self-monitoring of dietary intake, (3) Fitbit for self-monitoring of physical activity, (4) Bluetooth-enabled scale for daily weight, and (5) Bluetooth-enabled blood glucose monitor for testing blood glucose levels. There will be a 1-month follow-up after intervention. Assessments will occur at baseline and the end of follow-up. The individual interviews will be conducted with the participants to learn about their experience of technology use to self-manage their weight and diabetes at the end of study.

Interventions

BEHAVIORALself-regulation theory-based mHealth behavior intervention

Participants will receive a self-regulation theory-based mHealth behavior intervention (5 biweekly group sessions, 60 minutes /session). An experienced Certified Diabetes Educator from the Joslin Diabetes Center and PI (Dr. Zheng) who has been trained using self-regulation for weight loss will co-facilitate group sessions. The intervention combines diet modification and increased physical activity with a weekly weight loss goal as well as focuses on improving participants' three typical self-regulation strategies - self-monitoring, self-evaluation and self-reinforcement. Intervention duration will last 2 months with subsequent 1-month follow.

Sponsors

Joslin Diabetes Center
CollaboratorOTHER
Boston College
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>=65 years of age; * BMI between 27-40kg/m2 * Availability of wireless Internet service at home; * Stable body weight during the previous year (i.e., ±10 pounds) ; * Not being enrolled in another weight loss program in the past six months; * Diagnosed with type 2 diabetes for at least 2 years; * Prescribed insulin or oral medications for at least 1 year; * No changes in medications for at least 6 months before enrolling in the study; * Use the LoseIt! app on their computer or smartphone for the 5-day practice period; * Able to read, write and speak English.

Exclusion criteria

* Planning frequent travel, vacations or relocation in next 3 months; * Current use of weight loss medication; * Have a history of bariatric surgery; * Have participated in diabetes education in the previous 12 months; * Are unable to walk 2 blocks, or had an amputation of a lower limb, severe arthritis or other medical condition that prevents walking for exercise; * Have severe complications of diabetes, including renal disease (albumin/creatinine \>300 μg /mg), severe peripheral diabetic neuropathy, severe peripheral vascular disease, symptomatic autonomic neuropathy, history of myocardial infarction, congestive heart failure, or other severe cardiac disease or severe hypertension (systolic blood pressure greater than 160/90 mmHg); * Have a diagnosis of a serious mental illness, e.g. schizophrenia, bipolar disorder, substance abuse, and/or eating disorders; * Have severe visual, hearing or cognitive impairments (e.g., dementia, intellectual disability); * Unable or unwilling to use the mHealth technology equipment (toolkit) for data collection; * Do not speak, read and write English.

Design outcomes

Primary

MeasureTime frameDescription
AcceptabilityFrom baseline to the end of study (up to 3 months)Actual Use of Technology will be defined as binary (use vs. nonuse) for each day based on data-stamp information. Then we will calculate percent days of use over time.

Secondary

MeasureTime frameDescription
Percent weight changeFrom baseline to the end of study (up to 3 months)Percent weight changes over 3 months
StepsFrom baseline to the end of study (up to 3 months)Steps changes over 3 months
Calorie intakeMean steps over 3 monthsCalorie intake changes over 3 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026